You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CNSL

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)

Not yet recruiting
  • Central Nervous System Lymphoma
  • Hefei, Anhui, China
  • +4 more
Jan 26, 2023

CNS Lymphoma Trial in Berlin (Voraxaze Injectable Product)

Recruiting
  • CNS Lymphoma
  • Voraxaze Injectable Product
  • Berlin, Germany
    Charité Campus Benjamin Franklin (CBF)
Jul 18, 2022

CNS Lymphoma Trial (68Ga-PTF)

Recruiting
  • CNS Lymphoma
  • Aalborg, Denmark
  • +1 more
Jan 17, 2023

Lymphoma, B-Cell Trial in Taipei (non-intervention)

Recruiting
  • Lymphoma, B-Cell
  • non-intervention
  • Taipei, Taiwan
    National Taiwan University Hospital
Jun 14, 2021

Lymphoma, Non-Hodgkin Trial in China (DZD8586)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Beijing, Beijing, China
  • +5 more
Apr 25, 2023

Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib)

Not yet recruiting
  • Philadelphia-Positive ALL
  • Suzhou, Jiangsu, China
    First Affiliated Hospital of Soochow University
Jul 1, 2023

Primary Diffuse Large B-cell Lymphoma of the CNS (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS Trial

Suspended
  • Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
  • Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

CNS Lymphoma Trial in Nanchang (Human CD19-CD22 Targeted T Cells Injection)

Recruiting
  • Central Nervous System Lymphoma
  • Human CD19-CD22 Targeted T Cells Injection
  • Nanchang, Jiangxi, China
    The Second Affiliated Hospital of Nanchang University
Dec 13, 2022

r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

Not yet recruiting
  • B-cell Lymphoma
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Aug 9, 2022

CNS Lymphoma Trial in Beijing (Zanubrutinib)

Recruiting
  • CNS Lymphoma
  • Beijing, Beijing, China
    Peking University People's Hospital
Aug 1, 2022

Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib combined with chemo)

Not yet recruiting
  • Philadelphia-Positive ALL
  • Olverembatinib combined with chemotherapy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Jul 17, 2022

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Secondary CNS Lymphoma Trial in Beijing (Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab)

Recruiting
  • Secondary Central Nervous System Lymphoma
  • Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
May 25, 2022

Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Hangzhou (CAR-T cells, Ommaya Reservoir)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Non-Hodgkin's Lymphoma
  • CAR-T cells
  • Ommaya Reservoir
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital，College of Medicine, Zhejiang Univ
Oct 22, 2020

T-Cell Lymphoma, B-Cell Lymphoma Trial in Worldwide (enzastaurin)

Completed
Has Results
  • T-Cell Lymphoma
  • B-Cell Lymphoma
  • Anaheim, California
  • +13 more
Sep 23, 2020